Cladribine as a second line treatment in a child with isolated pulmonary Langerhans cell histiocytosis – case report

H. Marczak (Warszawa, Poland), J. Lange (Warszawa, Poland), K. Krenke (Warszawa, Poland), S. Boguslawski (Warszawa, Poland), K. Smalisz (Warszawa, Poland), I. Malinowska (Warszawa, Poland)

Source: International Congress 2018 – Orphan diseases in children
Session: Orphan diseases in children
Session type: Poster Discussion
Number: 623
Disease area: Interstitial lung diseases

Congress or journal article abstractSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Marczak (Warszawa, Poland), J. Lange (Warszawa, Poland), K. Krenke (Warszawa, Poland), S. Boguslawski (Warszawa, Poland), K. Smalisz (Warszawa, Poland), I. Malinowska (Warszawa, Poland). Cladribine as a second line treatment in a child with isolated pulmonary Langerhans cell histiocytosis – case report. 623

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: